Anixa Biosciences, Inc.

10-Q Quarter ended 2026-04-30 Jun 10, 2026 8-K Shareholder vote results; Regulation FD disclosure Mar 11, 2026 10-Q Quarter ended 2026-01-31 Mar 9, 2026 8-K Regulation FD disclosure Feb 9, 2026 10-K Fiscal year ended 2025-10-31 Jan 12, 2026 8-K Regulation FD disclosure Dec 12, 2025 10-Q Quarter ended 2025-07-31 Sep 10, 2025 10-Q Quarter ended 2025-04-30 May 28, 2025 8-K Shareholder vote results; Regulation FD disclosure Mar 21, 2025 10-Q Quarter ended 2025-01-31 Mar 11, 2025 10-K Fiscal year ended 2024-10-31 Jan 10, 2025 8-K Regulation FD disclosure Nov 8, 2024 10-Q Quarter ended 2024-07-31 Sep 6, 2024 10-Q Quarter ended 2024-04-30 Jun 4, 2024 8-K Entered a material agreement; Regulation FD disclosure May 8, 2024 8-K Shareholder vote results; Regulation FD disclosure Mar 22, 2024 10-Q Quarter ended 2024-01-31 Mar 12, 2024 10-K Fiscal year ended 2023-10-31 Jan 16, 2024 8-K Regulation FD disclosure Dec 7, 2023 10-Q Quarter ended 2023-07-31 Sep 6, 2023 10-Q Quarter ended 2023-04-30 Jun 14, 2023 8-K Regulation FD disclosure Apr 17, 2023 10-Q Quarter ended 2023-01-31 Mar 17, 2023 8-K Shareholder vote results; Regulation FD disclosure Mar 10, 2023 10-K Fiscal year ended 2022-10-31 Jan 4, 2023 8-K Regulation FD disclosure Dec 8, 2022 8-K Regulation FD disclosure Sep 29, 2022 10-Q Quarter ended 2022-07-31 Sep 9, 2022 8-K Other events Aug 17, 2022 10-Q Quarter ended 2022-04-30 Jun 10, 2022 8-K Director or officer change Apr 15, 2022 8-K Shareholder vote results; Regulation FD disclosure Mar 11, 2022 10-Q Quarter ended 2022-01-31 Mar 11, 2022 10-K Fiscal year ended 2021-10-31 Jan 4, 2022 8-K Item 5.08 Dec 9, 2021 8-K Regulation FD disclosure Oct 28, 2021 8-K Other events Oct 4, 2021 10-Q Quarter ended 2021-07-31 Sep 1, 2021 8-K Terminated a material agreement Jun 16, 2021 10-Q Quarter ended 2021-04-30 Jun 10, 2021